Inhibikase Therapeutics (IKT)
NASDAQ:IKT
Holding IKT?
Track your performance easily

Inhibikase Therapeutics (IKT) Stock Investors

104 Followers
Based on 757,103 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold IKT
On average, investors allocate 0.00% of their portfolios to IKT
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 757,103 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding IKT

1.7%
Last 7
Days
2.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding IKT, out of 757,103 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

IKT Investor Activity

Action
Any
Any
Investor Performance
Any
Any
Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.62%
$1.90
Based on the activity of 14,469 investors who made their portfolios public
The table shows changes in IKT in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

IKT Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
DraftKings
5.61%
-1.95%
+0.60%
33.45B
Consumer Cyclical
Riot Platforms
4.72%
-1.32%
-1.97%
2.18B
Financial
Marathon Digital Holdings
5.33%
-0.99%
-1.34%
4.52B
Financial
Plug Power
5.12%
-1.16%
-2.94%
1.85B
Industrials
Lucid Group
5.94%
-0.64%
-0.17%
8.44B
Consumer Cyclical
Blink Charging Co
5.32%
-1.73%
-3.80%
183.08M
Industrials
Coherus Biosciences
2.45%
+0.17%
-1.13%
120.97M
Healthcare
UiPath
3.53%
-1.79%
-3.10%
6.76B
Technology
XPeng, Inc. ADR
5.47%
-1.43%
-3.14%
8.60B
Consumer Cyclical
Block
4.24%
-1.24%
-2.76%
41.09B
Technology
Based on the activity of 757,103 active portfolios
Open your Smart Portfolio

IKT Investor Analysis

IKT investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
15.2%
of IKT holders
are under 35
Average Segment Performance
Average P/E Ratio20.16
Beta8.32
Dividend Yield3.50%
IKT investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
21.2%
of IKT holders
are between 35–55
Average Segment Performance
Average P/E Ratio18.25
Beta13.76
Dividend Yield3.65%
IKT investors over 55

Over 55

2.2%
Last 30 days
Holdings Change
63.6%
of IKT holders
are over 55
Average Segment Performance
Average P/E Ratio20.06
Beta4.95
Dividend Yield3.36%
Overview of age group and performance of IKT stock investors
See who invests in IKT according to age group and performance.

FAQ

How many retail Investors hold IKT?
<0.1% of TipRanks' retail investors hold IKT in their portfolios.
    What is IKT Investor Sentiment?
    IKT’s Investor Sentiment is Neutral.
      What percentage of retail investors changed their holding of IKT in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of IKT in the last 7 days.
        What percentage of retail investors changed their holding of IKT in the last 30 days?
        ▲ 2.2% of TipRanks' retail investors changed their holding of IKT in the last 30 days.
          What is the average age of retail investors who hold IKT?
          The average age of IKT Holders is over 55.
            What other stocks have IKT investors also bought?
            IKT Investors also bought DKNG, RIOT, MARA, PLUG, LCID, BLNK, CHRS, PATH, XPEV, SQ.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              BMRNBioMarin Pharmaceutical
              BSXBoston Scientific
              CPRXCatalyst Pharma
              EXELExelixis
              AVDLAvadel Pharmaceuticals
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis